Jonathan Violin
Officer, Director at Korsana Biosciences, Inc. (KRSA) since September 2026
Jonathan Violin has filed 28 insider reports with the SEC since January 2021, as officer and director at Korsana Biosciences, Inc. (KRSA), director at Crescent Biopharma, Inc. (CBIO) and director at Dianthus Therapeutics, Inc. /DE/ (DNTH) and at 3 more companies. Jonathan Violin made no open-market purchases or sales in the last 12 months. The latest filing, on September 10, 2026, is a Form 3: Jonathan Violin became an insider at Korsana Biosciences, Inc. (KRSA).
- Filings
- 28
- Companies
- 6
- Bought on market
- None
- Sold on market
- $6.11M
Companies where Jonathan Violin is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Officer, Directorsince September 2026 | 207,400 | $33.27 | Sep 10, 2026 | ||||
| Directorsince June 2025 | 69,515 | $12.40 | Jun 3, 2026 | ||||
| Directorsince September 2023 | $83.98 | May 22, 2026 | |||||
| Director | 0 | Jan 23, 2026 | |||||
| Officer, Director | 480,905 | $6.11M | $30.12 | Feb 7, 2023 | |||
| Directorsince January 2021 | 263,321 | Sep 22, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Sep 8, 2026KRSANew insider Violin Jonathan claimed ownership of 207,400 sharesForm 3New insider
- Jun 2, 2026CBIOSEC Form 4 filed by Director Violin JonathanForm 4Grant or award
- May 21, 2026DNTHSEC Form 4 filed by Director Violin JonathanForm 4Grant or award
- Jan 23, 2026ATXSDirector Violin Jonathan returned 263,321 shares to the company, closing all direct ownership in the companyForm 4Sale back to the company
- Jun 23, 2025CBIOSEC Form 4 filed by Director Violin JonathanForm 4Grant or award
- Jun 13, 2025CBIONew insider Violin Jonathan claimed ownership of 69,515 units of Ordinary SharesForm 3New insider
- Jun 11, 2025ATXSSEC Form 4 filed by Director Violin JonathanForm 4Grant or award
- May 22, 2025DNTHSEC Form 4 filed by Director Violin JonathanForm 4Grant or award
- Jun 5, 2024ATXSSEC Form 4 filed by Violin JonathanForm 4Grant or award
- May 23, 2024DNTHSEC Form 4 filed by Violin JonathanForm 4Grant or award
- Sep 11, 2023DNTHSEC Form 4 filed by Violin JonathanForm 4Grant or award
- Sep 11, 2023DNTHJonathan Violin became an insiderForm 3New insider
- Jun 2, 2023ATXSSEC Form 4 filed by Violin JonathanForm 4Grant or award
- Feb 2, 2023-$1.84MVRDNSEC Form 4: Violin Jonathan exercised 50,000 shares at a strike of $0.15 and sold $1,840,000 worth of shares (50,000 units at $36.80) as part of a pre-agreed trading plan (Amendment)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Feb 2, 2023-$1.84MVRDNSEC Form 4: Violin Jonathan sold $1,840,000 worth of shares (50,000 units at $36.80) as part of a pre-agreed trading plan, decreasing direct ownership by 10% to 430,905 unitsForm 4Open-market sale10b5-1 plan
- Jun 9, 2022ATXSSEC Form 4 filed by Violin Jonathan (Amendment)Form 4Grant or award
- Jun 9, 2022ATXSSEC Form 4 filed by Violin JonathanForm 4Grant or award
- Jun 1, 2022-$366KVRDNSEC Form 4: Violin Jonathan sold $366,000 worth of shares (30,000 units at $12.20) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 480,905 unitsForm 4Open-market sale10b5-1 plan
- May 2, 2022-$391KVRDNSEC Form 4: Violin Jonathan sold $391,200 worth of shares (30,000 units at $13.04) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 510,905 unitsForm 4Open-market sale10b5-1 plan
- Apr 4, 2022-$568KVRDNSEC Form 4: Violin Jonathan sold $567,636 worth of shares (30,000 units at $18.92) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 540,905 unitsForm 4Open-market sale10b5-1 plan
- Mar 2, 2022-$529KVRDNSEC Form 4: Violin Jonathan sold $529,491 worth of shares (30,000 units at $17.65) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 570,905 unitsForm 4Open-market sale10b5-1 plan
- Feb 3, 2022-$573KVRDNSEC Form 4: Violin Jonathan sold $572,818 worth of shares (30,000 units at $19.09) as part of a pre-agreed trading plan, decreasing direct ownership by 5% to 600,905 unitsForm 4Grant or awardOpen-market sale10b5-1 plan
- Dec 8, 2021VRDNSEC Form 4: Violin Jonathan converted options into 627,564 shares, increasing direct ownership by 18,784% to 630,905 unitsForm 4Conversion of a derivative
- Sep 20, 2021CATBSEC Form 4 filed by Violin JonathanForm 4Other acquisition or disposition
- Jun 2, 2021CATBSEC Form 4 filed by Violin JonathanForm 4Grant or award
- Jan 28, 2021CATBSEC Form 4 filed by Jonathan ViolinForm 4Grant or award
- Jan 28, 2021CATBSEC Form 3: Jonathan Violin claimed ownership of 543,373 units of Common StockForm 3New insider
- Jan 18, 2021VRDNSEC Form 4 filed by Jonathan ViolinForm 4Grant or award
Also sits on boards with
Officers and directors who share two or more companies with Jonathan Violin.
- Thomas W. Beetham2 shared: VRDN, DNTH
- Stephen F. Mahoney2 shared: VRDN, DNTH
- Andrew Komjathy2 shared: ATXS, CATB
- Benjamin Harshbarger2 shared: ATXS, CATB
- Noah Clauser2 shared: ATXS, CATB
- Fred Callori2 shared: ATXS, CATB
- Joanne T. Beck2 shared: ATXS, CATB
- Kenneth Bate2 shared: ATXS, CATB
- Andrew John Nichols2 shared: ATXS, CATB
Compare Jonathan Violin with
- Jonathan Violin vs Thomas W. Beetham2 shared
- Jonathan Violin vs Stephen F. Mahoney2 shared
- Jonathan Violin vs Andrew Komjathy2 shared
- Jonathan Violin vs Benjamin Harshbarger2 shared
- Jonathan Violin vs Noah Clauser2 shared
- Jonathan Violin vs Fred Callori2 shared
Other insiders at the same companies
- Ryan SavitzDNTH
- Edward CarrDNTH
- Ryan LynchCBIO
- Ellie Eunkyung ImCBIO
- Jan PinkasCBIO
- Joshua T BrummCBIO
- Jonathan McNeillCBIO
- Richard William ScalzoCBIO
- Barbara Harlin BisphamCBIO
- Michelle Patricia PerniceKRSA
- Nimish P ShahKRSA
- Fairmount Funds Management LLCVRDN
- Andrew GottesdienerKRSA
- Matthew James LeoniKRSA
- Heidi HensonKRSA
- Mark J. VignolaKRSA
Questions about Jonathan Violin
- What is Jonathan Violin's role at Korsana Biosciences, Inc.?
- Jonathan Violin reports to the SEC as officer and director at Korsana Biosciences, Inc. (KRSA), according to the latest filing on September 10, 2026. Jonathan Violin has also filed as director at Crescent Biopharma, Inc. (CBIO), director at Dianthus Therapeutics, Inc. /DE/ (DNTH), director at Astria Therapeutics, Inc. (ATXS) and officer and director at Viridian Therapeutics, Inc.\DE (VRDN).
- How many shares does Jonathan Violin own?
- After the latest filing that states it, Jonathan Violin directly owned 207,400 shares of Korsana Biosciences, Inc. (KRSA), 69,515 shares of Crescent Biopharma, Inc. (CBIO), 480,905 shares of Viridian Therapeutics, Inc.\DE (VRDN) and 263,321 shares of Astria Therapeutics, Inc. (CATB). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Jonathan Violin bought or sold stock recently?
- The most recent open-market sale was on February 2, 2023: sold 50,000 shares of Viridian Therapeutics, Inc.\DE (VRDN) for $1.84M at an average of $36.80.
- How do I get alerts when Jonathan Violin files?
- Follow Jonathan Violin on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Jonathan Violin filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Jonathan Violin (SEC CIK 0001730615). Totals count each trade once, skipping amendments whose original is on file, from Jan 20, 2021 on. View on SEC EDGAR